These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 9223731
1. Experimental gene therapy: the transfer of Tat-inducible interferon genes protects human cells against HIV-1 challenge in vitro and in vivo in severe combined immunodeficient mice. Sanhadji K, Leissner P, Firouzi R, Pelloquin F, Kehrli L, Marigliano M, Calenda V, Ottmann M, Tardy JC, Mehtali M, Touraine JL. AIDS; 1997 Jul; 11(8):977-86. PubMed ID: 9223731 [Abstract] [Full Text] [Related]
2. [In vitro and in vivo inhibition of HIV1 replication by retroviral transfer of interferon alpha, beta, or gamma genes: application to gene therapy of AIDS]. Leissner P, Calenda V, Marigliano M, Sanhadji K, Touraine JL, Pavirani A, Mehtali M. Ann Biol Clin (Paris); 1998 Jul; 56(2):167-73. PubMed ID: 9754242 [Abstract] [Full Text] [Related]
4. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells. Lapenta C, Santini SM, Proietti E, Rizza P, Logozzi M, Spada M, Parlato S, Fais S, Pitha PM, Belardelli F. Virology; 1999 Oct 10; 263(1):78-88. PubMed ID: 10544084 [Abstract] [Full Text] [Related]
6. Gene therapy for human immunodeficiency virus infection in the humanized SCID mouse model. Touraine JL, Sanhadji K, Sembeil R. Isr Med Assoc J; 2003 Dec 10; 5(12):863-7. PubMed ID: 14689754 [Abstract] [Full Text] [Related]
10. Activation of IFN-alpha, IFN-gamma, MxA, and IFN regulatory factor 1 genes in influenza A virus-infected human peripheral blood mononuclear cells. Ronni T, Sareneva T, Pirhonen J, Julkunen I. J Immunol; 1995 Mar 15; 154(6):2764-74. PubMed ID: 7876547 [Abstract] [Full Text] [Related]
11. Expression of human and macaque type I IFN transgenes interferes with HSV-1 replication at the transcriptional and translational levels: IFN-beta is more potent than IFN-alpha 2. Härle P, Lauret E, Pitha PM, De Maeyer E, Carr DJ. Virology; 2001 Nov 25; 290(2):237-48. PubMed ID: 11883188 [Abstract] [Full Text] [Related]
12. Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies. Mhashilkar AM, LaVecchio J, Eberhardt B, Porter-Brooks J, Boisot S, Dove JH, Pumphrey C, Li X, Weissmahr RN, Ring DB, Ramstedt U, Marasco WA. Hum Gene Ther; 1999 Jun 10; 10(9):1453-67. PubMed ID: 10395371 [Abstract] [Full Text] [Related]
14. Inhibition of human immunodeficiency virus type 1 by Tat/Rev-regulated expression of cytosine deaminase, interferon alpha2, or diphtheria toxin compared with inhibition by transdominant Rev. Ragheb JA, Couture L, Mullen C, Ridgway A, Morgan RA. Hum Gene Ther; 1999 Jan 01; 10(1):103-12. PubMed ID: 10022535 [Abstract] [Full Text] [Related]
15. Enhanced resistance to HIV-1 replication in U937 cells stably transfected with the human IFN-beta gene behind an MHC promoter fragment. Mace K, Seif I, Anjard C, De Maeyer-Guignard J, Dodon MD, Gazzolo L, De Maeyer E. J Immunol; 1991 Nov 15; 147(10):3553-9. PubMed ID: 1940355 [Abstract] [Full Text] [Related]
18. Activation of interferon response genes and of plasmacytoid dendritic cells in HIV-1 positive subjects with GB virus C co-infection. Lalle E, Sacchi A, Abbate I, Vitale A, Martini F, D'Offizi G, Antonucci G, Castilletti C, Poccia F, Capobianchi MR. Int J Immunopathol Pharmacol; 2008 Nov 15; 21(1):161-71. PubMed ID: 18336742 [Abstract] [Full Text] [Related]
19. RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model. Bai J, Banda N, Lee NS, Rossi J, Akkina R. Mol Ther; 2002 Dec 15; 6(6):770-82. PubMed ID: 12498773 [Abstract] [Full Text] [Related]